Inflammation and portal hypertension - the undiscovered country.
about
Endothelial dysfunction in cirrhosis: Role of inflammation and oxidative stressRethinking the role of non-selective beta blockers in patients with cirrhosis and portal hypertensionSystemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis.Evolution in the understanding of the pathophysiological basis of portal hypertension: How changes in paradigm are leading to successful new treatments.Cirrhotic Multiorgan Syndrome.Novel treatment options for portal hypertension.How to Face Chronic Liver Disease: The Sinusoidal Perspective.Boosting pigment epithelial-derived factor: a promising approach for the treatment of early portal hypertension.Abdominal infection reveals a rare disease.The soluble mannose receptor is released from the liver in cirrhotic patients, but is not associated with bacterial translocation.Copeptin is an independent prognostic factor for transplant-free survival in cirrhosis.Imbalance of von Willebrand factor and its cleaving protease ADAMTS13 during systemic inflammation superimposed on advanced cirrhosis.Portal vein thrombosis in cirrhosis: Controversies and latest developments.von Willebrand factor antigen as a therapeutic target of portal hypertension in cirrhosis.Breaking bad - the two sides of gut microbiota in portal hypertension.Post-Transcriptional Regulation of Hepatic DDAH1 with TNF Blockade Leads to Improved eNOS Function and Reduced Portal Pressure In Cirrhotic Rats.Portal vein thrombosis in cirrhosis: diagnosis, natural history, and therapeutic challenges.Andrographolide Ameliorates Liver Fibrosis in Mice: Involvement of TLR4/NF-κB and TGF-β1/Smad2 Signaling Pathways.Coeliac disease as a potential cause of idiopathic portal hypertension: a case report.
P2860
Q27023122-15632476-8E95-4AF4-A797-5E34ED2C421CQ28069136-F6E2998A-B6C2-4A14-AF24-AA18CC9889DFQ35995445-028731B3-3D83-4C7E-83E7-0F465AEB1B78Q38446357-25A1A7AF-CB3B-4D7C-969E-8A6774D85D94Q38538183-A3F35E47-4DD0-4B8A-A4EB-6BE5ED4D1AFBQ38680437-975019BD-8D21-407D-A524-C44C7BCA1228Q38940706-BF6A3F09-CA8B-4386-825E-B22C96294F03Q39474664-F4C77F77-7CA8-4D63-A9AD-381436BBE8E6Q40090599-1B13DB38-EED7-4CD0-97EC-086351E3F2B9Q40495697-5F275CE7-E233-433D-8CC2-18886B47FAD9Q41185456-A7E0C6E0-4EFA-4559-9977-E46FA1FD1D6CQ42202312-0790A743-AF33-49F7-9B84-DAE4533CFBF3Q42533695-405CA327-BDDF-4778-9231-41D703B6CE18Q42781768-12F89BCF-B4AA-4CD1-B218-BD25DBCBF856Q46892839-77FAAEDB-CE80-4092-9D93-14182B658F37Q47134026-14A35377-FAA8-4C96-A77D-9A0217899971Q53826596-0E827484-AACC-4D42-A62C-3B752D5EBA0CQ54981313-58BAC665-A28E-4780-B29C-1E2AE999A40AQ55407655-DA12D3B6-7188-47A8-AC89-DB5E2DBE3F96
P2860
Inflammation and portal hypertension - the undiscovered country.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Inflammation and portal hypertension - the undiscovered country.
@ast
Inflammation and portal hypertension - the undiscovered country.
@en
type
label
Inflammation and portal hypertension - the undiscovered country.
@ast
Inflammation and portal hypertension - the undiscovered country.
@en
prefLabel
Inflammation and portal hypertension - the undiscovered country.
@ast
Inflammation and portal hypertension - the undiscovered country.
@en
P2093
P50
P1476
Inflammation and portal hypertension - the undiscovered country
@en
P2093
Gautam Mehta
Juan Carlos Garcia-Pagan
Michael B Fallon
Rajiv Jalan
Vijay H Shah
P304
P356
10.1016/J.JHEP.2014.03.014
P577
2014-03-18T00:00:00Z